Of the people who have psoriasis, 80–90% have plaque psoriasis. The signs and symptoms of plaque psoriasis will vary from ...

Stull said that a number of prescription treatments exist for topical psoriasis, such as steroids and injectable therapies, ...

Deucravacitinib significantly improved skin-related quality of life of patients with moderate to severe plaque psoriasis, ...

The usual Bryhali (halobetasol) dosage for plaque psoriasis is a thin layer applied to the affected area of skin once per day. It’s important to use the dosage of Bryhali your doctor prescribes.

Discover a recent study that has investigated the efficacy of excimer light and topical methotrexate 1% hydrogel in managing ...

AX-158 has achieved clinical validation through its phase 2a trial for the treatment of patients with mild to moderate plaque ...

Zoryve can start to work after your first dose. In clinical trials, some people saw improvements in their plaque psoriasis symptoms or atopic dermatitis symptoms in as little as 2 weeks.

The use of risankizumab after poor response to 2 interleukin-17 inhibitors, secukinumab, and ixekizumab, was safe and effective in plaque psoriasis.

Dublin, Jan. 23, 2025 (GLOBE NEWSWIRE) -- The "Plaque Psoriasis Market by Treatment, by Route of Administration, by End-user, and by Region" report has been added to ResearchAndMarkets.com's offering.

Study highlights the efficacy and safety of tildrakizumab in improving physical, psychological, and social aspects of quality ...